Today, Congress is weighing legislation, the SOAR (Supplemental Oxygen Access Reform) Act, which will allow Lincare to bill the public for hundreds of millions more every year, raising rates and eliminating competitive billing. The bill is supported by patient advocates who are rightly interested in getting oxygen to patients who have been locked out of the system, but the cost of that inclusion is that Lincare will be even more firmly insulated from its corruption.
19/